VOC breath biomarkers in lung cancer

Clinica Chimica Acta

Volumn 459, Issue , 2016, Pages 5-9

  Saalberg, Yannick ^a   Wolff, Marcus ^a  

^a HAMBURG UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Biomarker; Breath analysis; Diagnostics; Lung cancer; Screening; VOC

Indexed keywords

2 BUTANONE; ETHYLBENZENE; HEXANAL; ISOPRENE; PROPANOL; STYRENE; VOLATILE ORGANIC COMPOUND; TUMOR MARKER;

BREATH ANALYSIS; CANCER SCREENING; CHEMOMETRICS; DIAGNOSTIC TEST; EARLY DIAGNOSIS; FOURIER TRANSFORMATION; GAS CHROMATOGRAPHY; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LUNG CANCER; MASS SPECTROMETRY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RELIABILITY; REVIEW; SOLID PHASE MICROEXTRACTION; BREATHING; LUNG NEOPLASMS;

BIOMARKERS, TUMOR; BREATH TESTS; HUMANS; LUNG NEOPLASMS; RESPIRATION; VOLATILE ORGANIC COMPOUNDS;

EID: 84977638407     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.05.013     Document Type: Review

References (56)

1. [1] World Health Organization, Fact sheet N297 - Cancer. Url: http://www.who.int/mediacentre/factsheets/fs297/en/ (Accessed January 2016).
2. [2] Inc. American Cancer Society, What are the key statistics about lung cancer?. Url: http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-key-statistics (Accessed January 2016).
3. [3] Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136 (2015), E359–E386.
4. [4] Rami-Porta, R., Crowley, J.J., Goldstraw, P., The revised TNM staging system for lung cancer. Ann. Thorac. Cardiovasc. Surg. 15 (2009), 4–9.
5. [5] Smith, R.A., von Eschenbach, A.C., Wender, R., Levin, B., Byers, T., Rothenberger, D., Brooks, D., et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J. Clin. 51 (2001), 38–75.
6. [6] WHO International Programme on Chemical Safety Biomarkers in Risk Assessment: Validity and Validation. Url: http://www.inchem.org/documents/ehc/ehc/ehc222.htm (Accessed January 2016).
7. [7] Gordon, S.M., Szidon, J.P., Krotoszynski, B.K., Gibbons, R.D., O'Neill, H.J., Volatile organic compounds in exhaled air from patients with lung cancer. Clin. Chem. 31 (1985), 1278–1282.
8. [8] McCulloch, M., Jezierski, T., Broffman, M., Hubbard, A., Turner, K., Janecki, T., Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr. Cancer Ther. 5 (2006), 30–39.
9. [9] Ligor, T., Pater, L., Buszewski, B., Application of an artificial neural network model for selection of potential lung cancer biomarkers. J. Breath Res., 9, 2015, 027106.
10. [10] Crohns, M., Saarelainen, S., Laitinen, J., Peltonen, K., Alho, H., Kellokumpu-Lehtinen, P., Exhaled pentane as a possible marker for survival and lipid peroxidation during radiotherapy for lung cancer—a pilot study. Free Radic. Res. 43 (2009), 965–974.
11. [11] Skeldon, K.D., McMillan, L.C., Wyse, C.A., Monk, S.D., Gibson, G., Patterson, C., et al. Application of laser spectroscopy for measurement of exhaled ethane in patients with lung cancer. Respir. Med. 100 (2006), 300–306.
12. [12] Krilaviciute, A., Heiss, J.A., Leja, M., Kupcinskas, J., Haick, H., Brenner, H., Detection of cancer through exhaled breath: a systematic review. Oncotarget 6 (2015), 38643–38657.
13. [13] US Environmental Protection Agency, Compendium of Methods for the Determination of Toxic Organic Compounds in Ambient Air, TO-15a. second ed., 1999.
14. [14] Mochalski, P., King, J., Unterkofler, K., Amann, A., Stability of selected volatile breath constituents in Tedlar, Kynar and Flexfilm sampling bags. Analyst 138 (2013), 1405–1418.
15. [15] Steeghs, M.M.L., Cristescu, S.M., Harren, F.J.M., The suitability of Tedlar bags for breath sampling in medical diagnostic research. Physiol. Meas. 28 (2007), 73–84.
16. [16] Hakim, M., Broza, Y.Y., Barash, O., Peled, N., Phillips, M., Amann, A., et al. Volatile organic compounds of lung cancer and possible biochemical pathways. Chem. Rev. 112 (2012), 5949–5966.
17. [17] Dent, A.G., Sutedja, T.G., Zimmerman, P.V., Exhaled breath analysis for lung cancer. J. Thorac. Dis. 5:Suppl. 5 (2013), 540–550.
18. [18] van de Kant, K.D.G., van der Sande, L.J.T.M., Jöbsis, Q., van Schayck, O.C.P., Dompeling, E., Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. Respir. Res., 13, 2012, 117.
19. [19] Filipiak, W., Ruzsanyi, V., Mochalski, P., Filipiak, A., Bajtarevic, A., Ager, C., et al. Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants. J. Breath Res., 6, 2012, 036008.
20. [20] Horváth, I., Lázár, Z., Gyulai, N., Kollai, M., Losonczy, G., Exhaled biomarkers in lung cancer. Eur. Respir. J. 34 (2009), 261–275.
21. [21] Mazzone, P.J., Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J. Thorac. Oncol. 3 (2008), 774–780.
22. [22] Pawliszyn, J., Theory of solid-phase microextraction. J. Chromatogr. Sci. 38 (2000), 270–278.
23. [23] Grote, C., Pawliszyn, J., Solid-phase microextraction for the analysis of human breath. Anal. Chem. 69 (1997), 587–596.
24. [24] Wehinger, A., Schmid, A., Mechtcheriakov, S., Ledochowski, M., Grabmer, C., Gastl, G.A., et al. Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas. Int. J. Mass Spectrom. 265 (2007), 49–59.
25. [25] Schwarz, K., Filipiak, W., Amann, A., Determining concentration patterns of volatile compounds in exhaled breath by PTR-MS. J. Breath Res., 3, 2009, 027002.
26. [26] Machado, R.F., Laskowski, D., Deffenderfer, O., Burch, T., Zheng, S., Mazzone, P.J., et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am. J. Respir. Crit. Care Med. 171 (2005), 1286–1291.
27. [27] Dragonieri, S., Annema, J.T., Schot, R., van der Schee, M.P.C., Spanevello, A., Carratú, P., et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 64 (2009), 166–170.
28. [28] Rocco, R., Incalzi, R.A., Pennazza, G., Santonico, M., Pedone, C., Bartoli, I.R., et al. BIONOTE e-nose technology may reduce false positives in lung cancer screening programmes. Eur. J. Cardiothorac. Surg., 2015.
29. [29] Handa, H., Usuba, A., Maddula, S., Baumbach, J.I., Mineshita, M., Miyazawa, T., Exhaled breath analysis for lung cancer detection using ion mobility spectrometry. PLoS One, 9, 2014, e114555.
30. [30] Westhoff, M., Litterst, P., Freitag, L., Urfer, W., Bader, S., Baumbach, J.I., Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 64 (2009), 744–748.
31. [31] Fu, X.A., Li, M., Knipp, R.J., Nantz, M.H., Bousamra, M., Noninvasive detection of lung cancer using exhaled breath. Cancer Med. 3 (2014), 174–181.
32. [32] Szulejko, J.E., McCulloch, M., Jackson, J., McKee, D.L., Walker, J.C., Solouki, T., Evidence for cancer biomarkers in exhaled breath. IEEE Sensors J. 10 (2010), 185–210.
33. [33] Phillips, M., Altorki, N., Austin, J.H.M., Cameron, R.B., Cataneo, R.N., Greenberg, J., et al. Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark. 3 (2007), 95–109.
34. [34] Phillips, M., Altorki, N., Austin, J.H.M., Cameron, R.B., Cataneo, R.N., Kloss, R., et al. Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin. Chim. Acta 393 (2008), 76–84.
35. [35] Bajtarevic, A., Ager, C., Pienz, M., Klieber, M., Schwarz, K., Ligor, M., et al. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer, 9, 2009, 348.
36. [36] Wang, Y., Hu, Y., Wang, D., Yu, K., Wang, L., Zou, Y., et al. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Cancer Biomark. 11 (2012), 129–137.
37. [37] Barash, O., Peled, N., Hirsch, F.R., Haick, H., Sniffing the unique “odor print” of non-small-cell lung cancer with gold nanoparticles. Small 5 (2009), 2618–2624.
38. [38] Chen, X., Xu, F., Wang, Y., Pan, Y., Lu, D., Wang, P., et al. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer 110 (2007), 835–844.
39. [39] Buszewski, B., Ligor, T., Jezierski, T., Wenda-Piesik, A., Walczak, M., Rudnicka, J., Identification of volatile lung cancer markers by gas chromatography-mass spectrometry: comparison with discrimination by canines. Anal. Bioanal. Chem. 404 (2012), 141–146.
40. [40] Capuano, R., Santonico, M., Pennazza, G., Ghezzi, S., Martinelli, E., Roscioni, C., et al. The lung cancer breath signature: a comparative analysis of exhaled breath and air sampled from inside the lungs. Sci. Rep., 5, 2015, 16491.
41. [41] Fuchs, P., Loeseken, C., Schubert, J.K., Miekisch, W., Breath gas aldehydes as biomarkers of lung cancer. Int. J. Cancer 126 (2010), 2663–2670.
42. [42] Kischkel, S., Miekisch, W., Sawacki, A., Straker, E.M., Trefz, P., Amann, A., Schubert, J.K., Breath biomarkers for lung cancer detection and assessment of smoking related effects-confounding variables, influence of normalization and statistical algorithms. Clin. Chim. Acta 411 (2010), 1637–1644.
43. [43] Ligor, M., Ligor, T., Bajtarevic, A., Ager, C., Pienz, M., Klieber, M., et al. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin. Chem. Lab. Med. 47 (2009), 550–560.
44. [44] Phillips, M., Cataneo, R.N., Cummin, A.R.C., Gagliardi, A.J., Gleeson, K., Greenberg, J., et al. Detection of lung cancer with volatile markers in the breath. Chest 123 (2003), 2115–2123.
45. [45] Phillips, M., Gleeson, K., Hughes, J.M., Greenberg, J., Cataneo, R.N., Baker, L., McVay, W.P., Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 353 (1999), 1930–1933.
46. [46] Poli, D., Carbognani, P., Corradi, M., Goldoni, M., Acampa, O., Balbi, B., et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir. Res., 6, 2005, 71.
47. [47] Poli, D., Goldoni, M., Corradi, M., Acampa, O., Carbognani, P., Internullo, E., et al. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 878 (2010), 2643–2651.
48. [48] Preti, G., Labows, J.N., Kostelc, J.G., Aldinger, S., Daniele, R., Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 432 (1988), 1–11.
49. [49] Rudnicka, J., Kowalkowski, T., Ligor, T., Buszewski, B., Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879 (2011), 3360–3366.
50. [50] Santonico, M., Lucantoni, G., Pennazza, G., Capuano, R., Galluccio, G., Roscioni, C., et al. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling. Lung Cancer 77 (2012), 46–50.
51. [51] Song, G., Qin, T., Liu, H., Xu, G.B., Pan, Y.Y., Xiong, F.X., et al. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer 67 (2010), 227–231.
52. [52] Steeghs, M.M.L., Cristescu, S.M., Munnik, P., Zanen, P., Harren, F.J.M., An off-line breath sampling and analysis method suitable for large screening studies. Physiol. Meas. 28 (2007), 503–514.
53. [53] Subramaniam, S., Thakur, R.K., Yadav, V.K., Nanda, R., Chowdhury, S., Agrawal, A., Lung cancer biomarkers: state of the art. J. Carcinog., 12, 2013, 3.
54. [54] Ulanowska, A., Kowalkowski, T., Trawińska, E., Buszewski, B., The application of statistical methods using VOCs to identify patients with lung cancer. J. Breath Res., 5, 2011, 046008.
55. [55] Miekisch, W., Schubert, J.K., Noeldge-Schomburg, G.F.E., Diagnostic potential of breath analysis—focus on volatile organic compounds. Clin. Chim. Acta 347 (2004), 25–39.
56. [56] Amann, A., Miekisch, W., Pleil, J., Risby, T., Schubert, J., Methodological issues of sample collection and analysis of exhaled breath. Horvath, I., de Jongste, J., (eds.) Exhaled Biomarkers, 2010, European Respiratory Society, 96–114.